Domů › Ulcerózní kolitida › Texas › San Antonio
Klinické studie Ulcerózní kolitida v San Antonio, TX
16 studií pro Ulcerózní kolitida hledá účastníky v lokalitách v San Antonio a okolí (do cca 30 mil). Otevřete studii a zjistěte, kdo se může zapojit a jak kontaktovat tým studie.
Oficiální text studie (anglicky)
Hledáte účastníky pro studii? Zvýrazněte ji nahoře na této stránce – $99 na 30 dní →
Extension Study of Long-term Safety and Efficacy of Tulisokibart in Participants With Crohn's Disease or Ulcerative Colitis (MK-7240-011)
Probíhá náborFáze 3
- Southern Star Research Institute ( Site 0299), San Antonio
Study of Advanced Therapies for the Treatment of Adult Participants With Moderately to Severely Active Crohn's Disease or Ulcerative Colitis
Probíhá náborFáze 2
- Southern Star Research Institute /ID# 280822, San Antonio
Confirmatory Clinical Study in Active Ulcerative Colitis
Probíhá náborFáze 2
- Southern Star Research Institute, San Antonio
A Study of Eltrekibart and Mirikizumab in Adult Patients With Moderately to Severely Active Ulcerative Colitis
Probíhá náborFáze 2
- Gastroenterology Research of San Antonio, San Antonio
Study of XmAb942 in Healthy Participants and Participants With Ulcerative Colitis
Probíhá náborFáze 1/2Vítáni zdraví dobrovolníci
- Xencor Investigative Site, San Antonio
A Study of Long-acting Antibodies Alone and in Combinations for Moderate to Severe Ulcerative Colitis
Probíhá náborFáze 2
- Site 002, San Antonio
A Protocol of Icotrokinra Therapy in Adult and Adolescent Participants With Moderately to Severely Active Ulcerative Colitis
Probíhá náborFáze 3
- Southern Star Research Institute, LLC, San Antonio
Mirikizumab Administered at the Same Time as Tirzepatide in Adult Participants With Moderately to Severely Active Ulcerative Colitis and Obesity or Overweight: Phase 3b Study
Probíhá náborFáze 3
- Gastroenterology Research of San Antonio, San Antonio
- Southern Star Research Institute, San Antonio
LY4268989 (MORF-057) Co-Administered With Mirikizumab in Adults With Moderately to Severely Active Ulcerative Colitis:
Probíhá náborFáze 2
- Southern Star Research Institute, San Antonio
A Master Protocol (IIBD): A Study of Multiple Drugs in Adults With Ulcerative Colitis or Crohn's Disease
Probíhá náborFáze 2
- Southern Star Research Institute, San Antonio
LY4268989 in Adults With Moderately to Severely Active Ulcerative Colitis
Probíhá náborFáze 2
- Southern Star Research Institute, San Antonio
A Study of Vedolizumab With Tofacitinib in Adults With Ulcerative Colitis (UC)
Probíhá náborFáze 4
- Gastroenterology Research of San Antonio, LLC, San Antonio
A Maintenance Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Ulcerative Colitis
Probíhá náborFáze 3
- Gastroenterology Research of San Antonio LLC - Site Number: 8400054, San Antonio
A Study of JNJ-78934804 in Participants With Moderately to Severely Active Ulcerative Colitis
Probíhá náborFáze 3
- Southern Star Research Institute, LLC, San Antonio
An Induction Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Ulcerative Colitis
Probíhá náborFáze 3
- Gastroenterology Research of San Antonio LLC - Site Number: 8400054, San Antonio
An Observational Study of Etrasimod in Adult Patients With Moderate to Severe Ulcerative Colitis
Probíhá náborObservační studie
- Brooke Army Medical center, San Antonio
- Brooke Army Medical center, San Antonio
Studie Ulcerózní kolitida v jiných městech
- New York City, NY23 studií
- Orlando, FL22 studií
- Miami, FL21 studií
- Houston, TX17 studií
- Chicago, IL15 studií
- Tacoma, WA15 studií
- San Diego, CA15 studií
- Tyler, TX14 studií
- Colorado Springs, CO14 studií
- Los Angeles, CA13 studií
- St. Louis, MO13 studií
- Washington, DC12 studií
Další studie v San Antonio
- Nemalobuněčný plicní karcinom59 studií
- Kolorektální karcinom46 studií
- Rakovina prsu46 studií
- Metastatický karcinom44 studií
- Rakovina (všechny typy)41 studií
- Obesity40 studií
- Diabetes mellitus 2. typu37 studií
- Nadváha34 studií
- Rakovina vaječníků31 studií
- Rakovina slinivky břišní31 studií
- Rakovina prostaty28 studií
- Rakovina endometria27 studií
Zdroj: ClinicalTrials.gov, data načtena 4. 10. 2026. Každá studie má vlastní kritéria způsobilosti; o účasti rozhoduje tým studie.